Moreover, while restoring the expression of the anti-tumor protein Rb, siRNA targeting E7 could overcome PTX-induced resistance by inhibiting the activation of the AKT pathway, and the resulting synergistic effect enhances tumor suppression in CC. This evidence concerns the gene AKT1 and neoplasm.